An Evaluation Of Mannkind Corp (NASDAQ: MNKD) Prospects

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Earlier, Yahoo Finance discussed this stock as it revealed INHALE-3 Study’s Initial Meal Challenge Results Comparing Afrezza® Head-To-Head With Multiple Daily Injections (MDI) and Insulin Pumps.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

MNKD belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Mannkind Corp is $1.33B. A total of 1.91 million shares were traded on the day, compared to an average of 3.11M shares.

In the most recent transaction, Castagna Michael sold 90,482 shares of MNKD for 4.00 per share on Dec 15 ’23. After the transaction, the Chief Executive Officer now owns 2,148,665 company shares. In a previous transaction on Dec 14 ’23, Castagna Michael sold 110,000 shares at 4.00 per share. MNKD shares that Chief Executive Officer owns now total 2,239,147.

Among the insiders who sold shares, Castagna Michael disposed of 10,000 shares on Nov 01 ’23 at a per-share price of $4.25. This resulted in the Chief Executive Officer holding 2,349,147 shares of MNKD after the transaction. In another insider transaction, Castagna Michael sold 10,000 shares at $4.61 per share on Oct 02 ’23. Company shares held by the Chief Executive Officer now total 2,359,147.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, MNKD has a high of $5.75 and a low of $3.17.

As of this writing, MNKD has an earnings estimate of $0.03 per share for the current quarter. EPS was calculated based on a consensus of 5 estimates, with a high estimate of $0.06 per share and a lower estimate of $0.01. The company reported an EPS of $0.01 in the last quarter, which was 150.00% higher than expectations of -$0.02.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. MNKD’s latest balance sheet shows that the firm has $204.12M in Cash & Short Term Investments as of fiscal 2021. There were $282.24M in debt and $48.35M in liabilities at the time. Its Book Value Per Share was -$0.91, while its Total Shareholder’s Equity was -$209.35M.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MNKD is Buy with a score of 4.67.

Most Popular

Related Posts